Biotech-Heavy ‘Nasdaq of Japan’ Is Asia’s Best-Performing Index
(Bloomberg) -- Japan's Mothers Index recovered to the 1,000 point milestone for the first time since December 2018 as the coronavirus pandemic became an unexpected tailwind for the startup board.
The index is up 27% in the past month, the most of any equity gauge in Asia. A surge in shares of AnGes Inc. on the back of hopes for its coronavirus vaccine candidate is among the reasons -- but far from the only one. The outbreak has been an unexpected boon for shares in many of the larger firms on the board, including flea market app operator Mercari Inc. and drug maker Sosei Group. Several companies that listed just in December, including cloud accounting firm Freee KK and telemedicine provider Medley Inc., have also benefited as the virus changes work and lifestyle habits in Japan.
“Normally it's just a few distinct themes on the index that are moving,” said Yasuo Sakuma, president of Libra Investments, “but now it's a whole range, from biotechnology to online to AI.” While many Topix companies are expected to make a slow recovery, he sees Mothers, with many companies focused on new services, as “highly likely to see a V-shaped recovery.”
The index is often considered the “Nasdaq of Japan,” having been formed in 1999 to capture the dot-com-era startup mania. Healthcare stocks, including biotechnology companies, now make up 32% of the index, while IT firms are at 27% -- a stark contrast to the large manufacturer-heavy Nikkei or Topix indexes.
“Three-quarters of the companies on the index are growth industries such as biotech or IT,” said Hideyuki Ishiguro, a senior strategist at Daiwa Securities. “Unlike manufacturers, Mothers firms have either not been negatively impacted by the pandemic, or are actually actively involved in changing the times, such as drug or vaccine makers.”
“This is the kind of market that only happens once every few years,” said Sakuma. “1,000 points is a mere stop along the way. In the mid-term, it can hit the the 2018 high” of the 1,300 point mark, he said.
Mothers has also benefited from its accessibility for retail investors, with some pointing to concerns that its two-month almost non-stop gain may be a short-term craze. “With the surge in people working from home, there are a lot of day traders in the forex markets,” said Masashi Samizo, a market analyst at SMBC Trust Bank. “It's likely small- and mid-caps, like those on Mothers, are seeing similar moves.”
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.